Investment company Flowstone Opportunity Fund (Current Portfolio) buys CRISPR Therapeutics AG during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Flowstone Opportunity Fund. As of 2021Q3, Flowstone Opportunity Fund owns 1 stocks with a total value of $1 million. These are the details of the buys and sells.
Here is the complete portfolio of FLOWSTONE OPPORTUNITY FUND. Also check out:
1. FLOWSTONE OPPORTUNITY FUND's Undervalued Stocks
2. FLOWSTONE OPPORTUNITY FUND's Top Growth Companies, and
3. FLOWSTONE OPPORTUNITY FUND's High Yield stocks
4. Stocks that FLOWSTONE OPPORTUNITY FUND keeps buying
- New Purchases: CRSP,
For the details of FLOWSTONE OPPORTUNITY FUND's stock buys and sells, go to https://www.gurufocus.com/guru/flowstone+opportunity+fund/current-portfolio/portfolio
These are the top 5 holdings of FLOWSTONE OPPORTUNITY FUND- CRISPR Therapeutics AG (CRSP) - 700,076 shares, 100.00% of the total portfolio. New Position
Flowstone Opportunity Fund initiated holding in CRISPR Therapeutics AG. The purchase prices were between $110.2 and $156.64, with an estimated average price of $126. The stock is now traded at around $100.260000. The impact to a portfolio due to this purchase was 100%. The holding were 700,076 shares as of 2021-09-30.
Here is the complete portfolio of FLOWSTONE OPPORTUNITY FUND. Also check out:
1. FLOWSTONE OPPORTUNITY FUND's Undervalued Stocks
2. FLOWSTONE OPPORTUNITY FUND's Top Growth Companies, and
3. FLOWSTONE OPPORTUNITY FUND's High Yield stocks
4. Stocks that FLOWSTONE OPPORTUNITY FUND keeps buying
